Five entities – four companies and one executive – are now being probed by the Competition Commission of India after complaints of anticompetitive stockiest-ship appointments. Pharmaceutical companies Cipla, Macleods Pharmaceutical and FDC Ltd are all under investigation, as well as the trade body Himachal Pradesh Society of Chemist and Druggist Alliance, as well as its president. According to reports, the CCI is looking into allegations that the trade body illegally controlled the appointment of stockist-ship of the pharmaceutical companies that are part of the Society. The CCI has recognized the complaints that competitors could not be granted stockish-ship due to the collusive agreements.
Featured News
Federal Court Gives Preliminary Approval to John Deere Right-to-Repair Settlement
May 19, 2026 by
CPI
SEC Pushes Tech-Driven Regulatory Overhaul to Modernize Public Markets
May 19, 2026 by
CPI
Fortnite Expands App Store Comeback as Epic Continues Fight With Apple
May 19, 2026 by
CPI
Compass Lexecon Expands Antitrust Expertise With New Academic Affiliates
May 19, 2026 by
CPI
Japan Raids Firms Over Suspected Bid-Rigging in Hokkaido Shinkansen Extension Project
May 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Unilateral Effects
Apr 28, 2026 by
CPI
A Net Present Value Approach to Merger Analysis
Apr 28, 2026 by
Joseph J Simons & Malcolm Coate
Generative AI and Competitive Disruption: Increasingly Relevant for Merger Analysis?
Apr 28, 2026 by
Andrea Coscelli, Emily Chissell, Nitika Bagaria & Tega Akati-Udi
Non-Price Unilateral Effects In Media Mergers
Apr 28, 2026 by
Lapo Filistrucchi & Teresa Oriani
Ecosystem Mergers and Unilateral Effects? A Framework for Assessing the Ecosystem Theory of Harm
Apr 28, 2026 by
Ethel Fonseca, George Tucker & Helder Vasconcelos